BioInsights

Despite their invaluable expertise and thoughtful feedback, peer reviewers often go unrecognized and are not formally acknowledged in publications. To acknowledge their contribution, we published a list of peer reviewers who gave feedback throughout 2024 – your expertise and thoughtful feedback were invaluable to advancing work in the fields of #cellandgenetherapy, #nucleicacids, #vaccines, and #immunooncology, and we deeply appreciate the time and effort you dedicated to the process. Thank you and happy holidays!

Don't miss out on the October Vaccine Insights issue! Featuring this month's spotlight on: RNA vaccines: formulation & production View below: https://buff.ly/3BwQe47

Don't miss out on the October Cell & Gene Therapy Insights issue! Featuring this month's spotlight on: Gene editing View below: https://buff.ly/3YO43UP

This #InternationalPodcastDay, we are showcasing some of the conversations that help fuel progress! 🎙️ 🔬 Earlier this year, Charlotte Barker spoke with Giorgio Zenere, PhD, MBA (Kite Pharma) and Dirk Windgassen (Miltenyi Biotec) to discuss the important role robust potency assays play in transforming the therapeutic promise of cell and gene therapies into clinical reality. You can have a listen to the discussion at the link below: https://buff.ly/450EgKD Want to stay up to date with all the latest from the BioInsights Podcast? Follow us at the link below or on Spotify, Apple Podcasts, or wherever you stream, to stay up to date with the latest from BioInsights https://buff.ly/4eMYtr3 #InternationalPodcastDay #CellAndGeneTherapy #PotencyAssays #genetherapy #celltherapy

How can you overcome the complexities of AAV purification to ensure both high purity and yield, while scaling up for large-scale manufacturing? Our founder, Elisa Manzotti, recently had the privilege of moderating an expert panel discussion alongside William Kish (Taysha Gene Therapies), Matthew Roach (BridgeBio) Nathalie Clement (Siren Biotechnology), and Nicolas Laroudie (Thermo Fisher Scientific), as they shared their experiences and expert insights into addressing the toughest hurdles in AAV downstream processing. Key points in their discussion included: • Navigating purification complexities to maximize yield and purity • Optimizing upstream processes with downstream needs in mind • Ensuring scalability and reproducibility for large-scale manufacturing • Meeting critical regulatory guidelines Did you miss this live discussion? You can view the webinar at your convenience below: https://lnkd.in/e7c-xfmE #AAV #GeneTherapy #Biotech #DownstreamProcessing #Scalability #Webinar

Don't miss out on the August Cell & Gene Therapy Insights issue! Featuring this month's spotlight on: Innovation in cellular immunotherapy: how to reach more patients? View below:

Don't miss out on the July Nucleic Acid Insights issue! In this month's edition, we explore nonclinical tools and technologies being employed in the clinical translation of #mRNAtherapeutics, and investigate the key challenge of enhancing the stability of #nucleicaciddrugs in vivo. View below:

Don't miss out on the June Cell and Gene Therapy Insights issue! Featuring this month's spotlight content: Viral and non-viral vector platform evolution View below:

Don't miss out on the May Vaccine Insights issue! Featuring this month's spotlight content: RNA vaccines: research directions View below:

Don't miss out on the May Nucleic Acid Insights issue! Featuring this month's spotlight content: mRNA processing and analysis View below: